Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.

scientific article published on 16 August 2017

Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1091206647
P356DOI10.1186/S12881-017-0448-X
P932PMC publication ID5559773
P698PubMed publication ID28814288

P50authorMohammed N NimirQ57089776
Hisham AltaybQ57903494
P2093author name stringMohamed D Dafaalla
Musaab M Alfaki
Muzamil Mahdi Abdel Hamid
Mona Ellaithi
Mohamed Adel Taha
Abdelmohaymin A Abdalla
Alsmawal A Elimam
Mohamed A Abdelrahim
Mohamed Ahmed Salih Hassan
Mohamed El-Fatih Moly Eldeen
Mohamed Elmogtba Mouaweia Mohamed Aabdein
Musab I Mohammed
P2860cites workIsolation of genomic DNA from human whole bloodQ78721624
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern PolandQ80243226
Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family historyQ82151956
The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51Q24323065
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesQ24531993
Gapped BLAST and PSI-BLAST: a new generation of protein database search programsQ24545170
Meta-analysis of BRCA1 and BRCA2 penetranceQ24654786
I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structureQ24812223
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriersQ27851474
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Q27861047
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1Q28115843
SIFT: Predicting amino acid changes that affect protein functionQ29547211
Identification of the breast cancer susceptibility gene BRCA2Q29616290
BRCA2 is required for homology-directed repair of chromosomal breaksQ29618799
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumQ29619206
Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfacesQ30396003
BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family historyQ33330316
Breast cancer in Sub-Saharan Africa: opportunities for preventionQ33622597
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysisQ33845209
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genesQ33942332
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutationsQ33946674
The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the populationQ33991747
Variation in cancer risks, by mutation position, in BRCA2 mutation carriersQ34044197
Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancerQ34335495
Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanismsQ35081603
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsQ35527158
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerQ35957703
Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patientsQ36003635
Screening of BRCA1/2 Mutations Using Direct Sequencing in Indonesian Familial Breast Cancer CasesQ36028711
Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancerQ36135879
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancerQ36286597
BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families.Q36471022
Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast CancerQ36656262
A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancerQ36770256
Genetic susceptibility for breast cancer: how many more genes to be found?Q36820486
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testingQ37176931
Hereditary breast cancer: new genetic developments, new therapeutic avenuesQ37199029
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer familiesQ37304615
BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer familiesQ37323349
Implementation of a breast cancer genetic service in South Africa - lessons learned.Q38124050
Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient?Q38750393
Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patientsQ38904251
Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancerQ39009508
A novel BRCA2 in frame deletion in a Tunisian woman with early onset sporadic breast cancerQ39040163
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer familiesQ39395789
Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.Q39395809
High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer familiesQ39395816
BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variantsQ39514959
Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.Q39534663
Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic CancerQ39635066
The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsQ41226231
Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer StudyQ41409355
Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burdenQ41835115
Predicting functional effect of human missense mutations using PolyPhen-2.Q42406410
Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patientsQ43073348
Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancerQ43844860
High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patientsQ44634590
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.Q44946113
BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factorsQ46490970
Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestryQ47445017
Cancer variation associated with the position of the mutation in the BRCA2 geneQ47636266
A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South AfricaQ48654661
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancerQ50690518
MutationTaster2: mutation prediction for the deep-sequencing age.Q52877992
Internal repeats in the BRCA2 protein sequenceQ53173241
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancerQ57693923
Phenotypic effects of heterozygosity for a BRCA2 mutationQ63383838
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivoQ64388833
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneQ71955901
Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancerQ73096316
P433issue1
P921main subjectheterozygosityQ124059385
P304page(s)85
P577publication date2017-08-16
P1433published inBMC Medical GeneticsQ15759918
P1476titleMonoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer
P478volume18

Reverse relations

Q64039257BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestrycites workP2860

Search more.